Skip to content

Clinical trials

Adenocarcinoma of Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Country / region: China Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20123
20132
20143
20154
20166
20173
20185
20197
20207
20215
20226
20238
202411
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status26
Completed21
Recruiting20
Not yet recruiting7
Terminated2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University12
Shanghai Pulmonary Hospital, Shanghai, China10
Sun Yat-sen University4
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology4
Cancer Institute and Hospital, Chinese Academy of Medical Sciences3
Geneplus-Beijing Co. Ltd.3
Henan Cancer Hospital3
Novartis Pharmaceuticals3
First People's Hospital of Hangzhou2
Hunan Province Tumor Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung78
Carcinoma, Non-Small-Cell Lung16
Lung Neoplasms16
Pancreatic Neoplasms4
Colorectal Neoplasms3
Ovarian Neoplasms3
Brain Neoplasms2
Bronchial Neoplasms2
Endometrial Neoplasms2
Neoplasms2

Trials

Showing 26 to 50 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.